Blindness News and Research

RSS

Triple therapy approach helps Type 1 diabetes patients improve blood sugar control, lose weight

A combination of three medications—dapagliflozin, liraglutide and insulin—helped people with Type 1 diabetes improve blood sugar control and lose weight, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

5 Aug 2016

Studies highlight key role for vitamin A metabolite retinoic acid in ocular fibrosis

Mucous membrane pemphigoid is an autoimmune disease that causes inflammation and scarring in mucosal tissues. Affected individuals frequently exhibit scarring in the eye, which can lead to blindness in as many as 20% of patients.

4 Aug 2016

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases.

4 Aug 2016

Second annual USC VR Hackathon for international coders, designers focuses on Medical Empathy Machine

Kicking off its second annual virtual reality (VR) Hackathon, the University of Southern California Center for Body Computing announced this year's focus of the competition is "Medical Empathy Machine," showcasing the potential of VR to change medicine and patient experience through emotion, compassion and empathy.

30 Jul 2016

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.

28 Jul 2016

Researchers find potential way for delivering gene therapy to treat eye diseases

Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection.

27 Jul 2016

Mice study shows stem cell infusion could help treat glaucoma

An infusion of stem cells could help restore proper drainage for fluid-clogged eyes at risk for glaucoma. That's the upshot of a study led by a Veterans Affairs and University of Iowa team.

26 Jul 2016

Study pinpoints how immune abnormalities in retina may lead to macular degeneration

In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.

19 Jul 2016

Researchers develop first protective vaccine against insidious STI

The first steps towards developing a vaccine against an insidious sexual transmitted infection (STI) have been accomplished by researchers at McMaster University.

19 Jul 2016

IU researchers create virtual tissue model of diabetic retinopathy

By combining data on optometry patient's eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye.

15 Jul 2016

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report that their investigational therapy for retinitis pigmentosa (RP) has demonstrated a favorable safety and tolerability profile in an ongoing Phase I/II clinical trial.

14 Jul 2016

New, minimally invasive procedure may be effective for patients with FED

A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant.

13 Jul 2016

New eye test could help detect glaucoma earlier than current techniques

UNSW Australia scientists have developed a testing protocol that identifies the blinding eye disease glaucoma four years earlier than current techniques.

12 Jul 2016

Scientists succeed in restoring multiple key aspects of vision in mice

Experiments conducted under the leadership of a Stanford University School of Medicine investigator have succeeded, for the first time, in restoring multiple key aspects of vision in mammals.

11 Jul 2016

Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana is having a positive impact on the bottom line of Medicare's prescription drug benefit program in states that have legalized its use for medicinal purposes, according to University of Georgia researchers in a study published today in the July issue of Health Affairs.

8 Jul 2016

New genetic test provides rapid diagnosis of mitochondrial disease

Newcastle researchers have developed a genetic test providing a rapid diagnosis of mitochondrial disorders to identify the first patients with inherited mutations in a new disease gene.

7 Jul 2016

TKCI Srujana Innovation Award launched to combat corneal blindness

The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop’ at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India.

5 Jul 2016

Risk of blindness from spinal-fusion surgery has declined, study shows

The risk of blindness caused by spinal fusion, one of the most common surgeries performed in the U.S., has dropped almost three-fold since the late 1990s, according to the largest study of the topic to date.

1 Jul 2016

Researchers develop 2D culture system that mimics development of the whole eye

Research groups led by Professor Kohji Nishida of the Department of Ophthalmology and Endowed Associate Professor Ryuhei Hayashi of the Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, developed a 2D culture system which mimics the development of the whole eye by promoting cell-autonomous differentiation of human iPS cells.

30 Jun 2016

Transorbital ACS can improve vision in patients with glaucoma, optic nerve damage

Vision loss due to glaucoma or optic nerve damage is generally considered irreversible. Now a new prospective, randomized, multi-center clinical trial demonstrates significant vision improvement in partially blind patients after 10 days of noninvasive, transorbital alternating current stimulation.